The Wall Street Transcript
The Wall Street Transcript - In-Depth Interviews for Investors
Healthcare >> CEO Interviews >> March 11, 2016

Interview with the CEO: iCAD, Inc. (NASDAQ:ICAD)

Ferry, Kenneth M.
Kenneth M. Ferry, as Chief Executive Officer of iCAD, Inc., brings two decades of extensive experience in the management and leadership of health care technology organizations, with more than a decade of direct responsibility to the organizations’ P&L. Mr. Ferry’s previous experience has clearly demonstrated his ability to lead unprecedented growth. He was most recently Senior Vice President and General Manager for the Global Patient Monitoring business for Philips Medical Systems, the market leader in a $2.5 billion industry. In this role, he was responsible for research and development, marketing, business development, supply chain and manufacturing, quality and regulatory, finance and human resources. Mr. Ferry was named a Senior Vice President at Philips Medical Systems Division in 2001. From 1983 to 2001, Mr. Ferry served in a number of management positions with Hewlett-Packard and Agilent Technologies. As a Vice President and General Manager in the Hewlett-Packard/Agilent Technologies Healthcare Solutions Group, he was one of the key executives responsible for the sale of Agilent’s Medical Solutions Group to Philips in August 2001. Prior to this, beginning in 1997, he served as Vice President and General Manager of North American Field Operations for Hewlett-Packard and Agilent Technologies. He was responsible for sales, service, and marketing for patient monitoring, cardiac ultrasound, defibrillation, diagnostic EKG and information technology solutions. In addition to his role as Chief Executive Officer, Mr. Ferry also serves as a member of iCAD’s board of directors. Mr. Ferry is a graduate of the Boston College, School of Management in Chestnut Hill, Massachusetts. Profile
TWST: Can you provide a brief overview of the company?

Mr. Ferry: iCAD operates in two distinct areas of oncology: cancer detection and cancer treatment. We make

Top Company Interviews

Microsoft Corporation
Intel Corporation
Pfizer, Inc.
General Electric Company
Walmart Inc.
International Business Machines Corporation
Citigroup Inc.
Exxon Mobil Corporation
Bank of America Corporation
Dell Inc.
Verizon Communications Inc.
Alphabet Inc

Register for a Free Account to gain greater access to The Wall Street Transcript right now

CEO INTERVIEWS
Interview with the CEO: Pasithea Therapeutics Corp. (NASDAQ:KTTA)
Interview with the CEO: BetterLife Pharma Inc. (OTCMKTS:BETRF)
Interview with the CEO: Cansortium Inc. (OTCMKTS:CNTMF)
SECTOR ROUNDTABLES
Natural Gas Weighs Heavy On E&P Near-Term Prospects
Roundtable Forum:optimism Despite Uncertainty In For-profit Education
Roundtable Forum:a Shift In Focus To Natural Gas From Oil
MONEY MANAGER INTERVIEWS
Profitability Strategy Pays Off for Bank IT Company Q2 Holdings
Three Mid-Cap Names Using Their Balance Sheets to Create Value
Look Beyond Traditional Emerging Markets for More Diversification, Less Risk
ANALYST INTERVIEWS
Five Companies Dominate in Psychedelics-Based Drug Development
Cidara’s Long-Acting Antiviral Drug Could Be a Game Changer
Spotting Potential in the High-Risk, High Reward Neuroscience Space
Since 1963
© The Wall Street Transcript 2016, 2024
Terms and Conditions
Privacy Policy